Home › Funds › JPMorgan › JPMorgan Small Cap Growth Fund
Fund family: JPMorgan · Filed by JPMORGAN TRUST II (CIK 763852) · SEC series S000003859
Share classes and tickers: JGLYX (C000190883), JGRQX (C000190882), JGSMX (C000093779), JGSVX (C000173240), JISGX (C000010812), JSGZX (C000070647), OGGFX (C000010811), OSGCX (C000010815), PGSGX (C000010813)
“With management” counts the items where the fund’s own filing gives management’s recommendation (FOR or AGAINST): 991 with, 9 against, 0 abstentions (not counted as with management); 2 items carried no recommendation. Shareholder proposals: 3 FOR, 4 AGAINST, 0 abstained, by the filing’s own vote-source field.
The same two figures as JPMorgan’s manager page (270,893 ballot items across 111 funds and accounts), counted the same way for this fund.
| 2025-2026 | This fund | Items | JPMorgan | Items |
|---|---|---|---|---|
| Voted FOR the board's own proposals (directors, pay, auditor, capital, transactions, fund matters) | 98.2% | 956 | 93.4% | 220,206 |
| Backed environmental and social shareholder proposals at US companies | n/a | 1 | 5.5% | 2,647 |
Each ballot item this fund voted is set against the votes of the other JPMorgan funds and accounts on the same item (same meeting, same proposal): “most funds” is a strict majority of at least three of them, FOR against AGAINST, WITHHOLD or ABSTAIN, with split votes and items not voted left out. Funds in one family can follow separate voting policies, for example ESG funds, sub-advised funds and funds using pass-through voting.
Voted the same way as most JPMorgan funds on all 900 items where a comparison was possible.
The same votes as “with management” above, by the sector of the company voted on. 92.4% of this fund’s 1,000 such votes could be given a sector; the other 76 (7.6%) are at companies without one and are not in the table.
| Sector | Votes | Against management | Share |
|---|---|---|---|
| Consumer Discretionary | 241 | 4 | 1.7% |
| Health Care | 195 | 0 | 0.0% |
| Industrials | 171 | 2 | 1.2% |
| Technology | 161 | 0 | 0.0% |
| Finance | 92 | 0 | 0.0% |
| Energy | 26 | 0 | 0.0% |
| Telecommunications | 16 | 1 | 6.3% |
| Real Estate | 12 | 0 | 0.0% |
| Utilities | 10 | 0 | 0.0% |
| Proposal type | Items | Against management |
|---|---|---|
| Director Elections | 664 | 0 |
| Audit-related | 122 | 0 |
| Say-on-Pay | 120 | 0 |
| Compensation | 39 | 0 |
| Corporate Governance | 39 | 6 |
| Capital Structure | 17 | 0 |
| Shareholder Rights and Defenses | 6 | 2 |
| Extraordinary Transactions | 4 | 0 |
| Environment or Climate | 1 | 1 |
Position = shares voted × a recent share price, for US-listed shares of companies with a page on this site; an estimate for ranking only.
| Company | Meeting | Est. position | Items | Against mgmt |
|---|---|---|---|---|
| Nextracker Inc. | August 18, 2025 | $66M | 5 | 0 |
| Modine Manufacturing Company | August 21, 2025 | $54M | 6 | 0 |
| THE CHEFS' WAREHOUSE, INC. | May 8, 2026 | $49M | 10 | 0 |
| BLOOM ENERGY CORPORATION | May 21, 2026 | $47M | 8 | 0 |
| DIGITALOCEAN HOLDINGS, INC. | June 15, 2026 | $37M | 4 | 0 |
| FIRSTCASH HOLDINGS, INC. | June 9, 2026 | $35M | 6 | 0 |
| LIFE TIME GROUP HOLDINGS, INC. | April 22, 2026 | $33M | 7 | 0 |
| SPYRE THERAPEUTICS INC. | May 27, 2026 | $33M | 6 | 0 |
| Meeting | Company | Proposal | Fund | Mgmt |
|---|---|---|---|---|
| August 4, 2025 | Eagle Materials Inc. | Declassify the Board of Directors Shareholder proposal | For | Against |
| May 11, 2026 | MKS INC. | A shareholder proposal to reduce the threshold percentage of shareholders required to call a special meeting of shareholders from 40% to 10%, if properly presented at the meeting. Shareholder proposal | Against | For |
| April 22, 2026 | LEVI STRAUSS & CO | Shareholder proposal, if properly presented at the meeting, requesting Bylaw Amendment related to Sustainability ROI Report by Audit Committee. Shareholder proposal | Against | For |
| May 14, 2026 | WYNDHAM HOTELS & RESORTS, INC. | To vote on a stockholder proposal, if properly presented at the meeting, regarding stockholder ability to act by written consent. Shareholder proposal | For | Against |
| May 7, 2026 | WOLVERINE WORLD WIDE, INC. | Shareholder proposal regarding new climate change polices or practices. Shareholder proposal | Against | For |
| April 30, 2026 | LITHIA MOTORS, INC. | Vote on a shareholder proposal requesting a change to our board leadership structure, if properly presented. Shareholder proposal | Against | For |
| May 20, 2026 | LUMEN TECHNOLOGIES, INC. | Approval of a shareholder proposal regarding a shareholder right to vote for or against a poison pill. Shareholder proposal | For | Against |
| December 11, 2025 | Sportradar Group AG | Additional Voting Instructions - Shareholder Proposals (Voting) | Against | For |
| May 20, 2026 | SPORTRADAR GROUP AG | Motions by shareholders | Against | For |
1,012 ballot items at 127 meetings in 2025-2026. Download all votes (CSV)
Recent votes against management’s recommendation at large companies.
In the 2025-2026 proxy season, JPMorgan Small Cap Growth Fund (JGLYX) voted at 127 shareholder meetings of 125 companies, on 1,012 ballot items in all. Where management made a recommendation, the fund followed it on 99.1% of the items and voted against it 9 times. Its most frequent area of disagreement was corporate governance (6 of its votes against management). It voted on 7 shareholder proposals. It voted FOR the board's own proposals more often than JPMorgan's funds as a whole (98.2% against 93.4%). It voted the same way as most JPMorgan funds on every item where a comparison was possible.
Every figure is derived from the fund’s own Form N-PX filings with the SEC, read item by item: one ballot item is the fund’s vote on one proposal at one meeting, and an item filed twice in the season is counted once. Percentages count items, never shares. A season is published only with at least 250 ballot items at 15 meetings. Built November 18, 2026; the family figures are those of JPMorgan’s manager page. The interactive database shows the same votes company by company, with every other fund that voted.